Vanguard Group Inc Organovo Holdings, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Organovo Holdings, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 353,612 shares of ONVO stock, worth $166,197. This represents 0.0% of its overall portfolio holdings.
Number of Shares
353,612
Previous 353,612
-0.0%
Holding current value
$166,197
Previous $364,000
26.37%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ONVO
# of Institutions
36Shares Held
2.33MCall Options Held
18.8KPut Options Held
0-
Armistice Capital, LLC New York, NY929KShares$436,6300.01% of portfolio
-
Prescott Group Capital Management, L.L.C. Tulsa, OK474KShares$222,7810.06% of portfolio
-
Black Rock Inc. New York, NY142KShares$66,8370.0% of portfolio
-
Geode Capital Management, LLC Boston, MA110KShares$51,8700.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il79.3KShares$37,2510.0% of portfolio
About ORGANOVO HOLDINGS, INC.
- Ticker ONVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,712,020
- Market Cap $4.09M
- Description
- Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...